The discovery, commercialization, and routine administration of antimicrobial compounds to
treat infections revolutionized modern medicine and changed the therapeutic paradigm. …

… JM Munita is supported in part by a grant from the Chilean Ministry of Education and by
Clinical Alemana de Santiago and Universidad del Desarrollo School of Medicine, Chile. CA …

Daptomycin (DAP) is a cyclic lipopeptide with in vitro activity against a variety of Gram‐positive
pathogens, including multidrug‐resistant organisms. Since its introduction into clinical …

Objectives In the context of the coronavirus disease 2019 (COVID-19) pandemic, the
development and validation of rapid and easy-to-perform diagnostic methods are of high priority. …

Background Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a global threat. We
therefore analysed the bacterial characteristics of CRKP infections and the clinical outcomes of …

Background Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a global threat,
but the distribution and clinical significance of carbapenemases are unclear. The aim of this …

<p id="p001">We report the case of a patient from Brazil with a bloodstream infection caused
by a strain of methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) that was …

… faecalis S613 (DAP-susceptible) (a to e) and R712 (DAP-resistant) (f to j) cells at increasing
concentrations of the fluorescent antibiotic. The images within each panel show bacterial …

Daptomycin (DAP) is a lipopeptide antibiotic frequently used as a “last-resort” antibiotic against
vancomycin-resistant Enterococcus faecium (VRE). However, an important limitation for …

Staphylococcus aureus is an important pathogen causing a spectrum of diseases ranging
from mild skin and soft tissue infections to life-threatening conditions. Bloodstream infections …